Your browser doesn't support javascript.
loading
Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial.
Derde, Lennie P G; Cooper, Ben S; Goossens, Herman; Malhotra-Kumar, Surbhi; Willems, Rob J L; Gniadkowski, Marek; Hryniewicz, Waleria; Empel, Joanna; Dautzenberg, Mirjam J D; Annane, Djillali; Aragão, Irene; Chalfine, Annie; Dumpis, Uga; Esteves, Francisco; Giamarellou, Helen; Muzlovic, Igor; Nardi, Giuseppe; Petrikkos, George L; Tomic, Viktorija; Martí, Antonio Torres; Stammet, Pascal; Brun-Buisson, Christian; Bonten, Marc J M.
Afiliação
  • Derde LPG; Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht, Netherlands. Electronic address: lderde@umcutrecht.nl.
  • Cooper BS; Centre for Clinical Vaccinology and Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
  • Goossens H; Department of Medical Microbiology, Vaccine & Infectious Disease Institute, Antwerp University, University Hospital Antwerp, Antwerp, Belgium.
  • Malhotra-Kumar S; Department of Medical Microbiology, Vaccine & Infectious Disease Institute, Antwerp University, University Hospital Antwerp, Antwerp, Belgium.
  • Willems RJL; Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, Netherlands.
  • Gniadkowski M; Department of Molecular Microbiology, National Medicines Institute, Warsaw, Poland.
  • Hryniewicz W; Division of Microbiology and Infection Prevention, National Medicines Institute, Warsaw, Poland.
  • Empel J; Department of Molecular Microbiology, National Medicines Institute, Warsaw, Poland.
  • Dautzenberg MJD; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands.
  • Annane D; Service de Réanimation Médicale, Hôpital Raymond Poincaré, Garches, France.
  • Aragão I; Polyvalent Intensive Care Unit, Central Hospital of Porto, Porto, Portugal.
  • Chalfine A; Infection Control Unit, Groupe Hospitalier Paris-Saint Joseph, Paris, France.
  • Dumpis U; Department of Infection Control, Paul Stradins University Hospital, Riga, Latvia.
  • Esteves F; ICU and Emergency Department, Centro Hospitalar Trás-os-Montes e Alto Douro, Vila Real, Portugal.
  • Giamarellou H; 4th Department of Internal Medicine, Athens University Medical School, Attikon General Hospital, Athens, Greece.
  • Muzlovic I; Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre Ljubljana, Ljubljana, Slovenia.
  • Nardi G; Shock and Trauma Unit, Intensive Care Unit, Azienda Ospedaliera S Camillo Forlanini, Rome, Italy.
  • Petrikkos GL; Infectious Diseases Unit, Laikon General Hospital, University of Athens, Athens, Greece.
  • Tomic V; Laboratory for Respiratory Microbiology, University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia.
  • Martí AT; Pneumology Department, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Ciber de Enfermedades Respiratorias, University of Barcelona, Barcelona, Spain.
  • Stammet P; Intensive Care Unit, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg.
  • Brun-Buisson C; Service de réanimation médicale and INSERM U657, Institut Pasteur, APHP GH Henri Mondor, Université Paris Est-Créteil, Creteil, France.
  • Bonten MJM; Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, Netherlands; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands.
Lancet Infect Dis ; 14(1): 31-39, 2014 Jan.
Article em En | MEDLINE | ID: mdl-24161233
ABSTRACT

BACKGROUND:

Intensive care units (ICUs) are high-risk areas for transmission of antimicrobial-resistant bacteria, but no controlled study has tested the effect of rapid screening and isolation of carriers on transmission in settings with best-standard precautions. We assessed interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in European ICUs.

METHODS:

We did this study in three phases at 13 ICUs. After a 6 month baseline period (phase 1), we did an interrupted time series study of universal chlorhexidine body-washing combined with hand hygiene improvement for 6 months (phase 2), followed by a 12-15 month cluster randomised trial (phase 3). ICUs were randomly assigned by computer generated randomisation schedule to either conventional screening (chromogenic screening for meticillin-resistant Staphylococcus aureus [MRSA] and vancomycin-resistant enterococci [VRE]) or rapid screening (PCR testing for MRSA and VRE and chromogenic screening for highly resistant Enterobacteriaceae [HRE]); with contact precautions for identified carriers. The primary outcome was acquisition of resistant bacteria per 100 patient-days at risk, for which we calculated step changes and changes in trends after the introduction of each intervention. We assessed acquisition by microbiological surveillance and analysed it with a multilevel Poisson segmented regression model. We compared screening groups with a likelihood ratio test that combined step changes and changes to trend. This study is registered with ClinicalTrials.gov, number NCT00976638.

FINDINGS:

Seven ICUs were assigned to rapid screening and six to conventional screening. Mean hand hygiene compliance improved from 52% in phase 1 to 69% in phase 2, and 77% in phase 3. Median proportions of patients receiving chlorhexidine body-washing increased from 0% to 100% at the start of phase 2. For trends in acquisition of antimicrobial-resistant bacteria, weekly incidence rate ratio (IRR) was 0·976 (0·954-0·999) for phase 2 and 1·015 (0·998-1·032) for phase 3. For step changes, weekly IRR was 0·955 (0·676-1·348) for phase 2 and 0·634 (0·349-1·153) for phase 3. The decrease in trend in phase 2 was largely caused by changes in acquisition of MRSA (weekly IRR 0·925, 95% CI 0·890-0·962). Acquisition was lower in the conventional screening group than in the rapid screening group, but did not differ significantly (p=0·06).

INTERPRETATION:

Improved hand hygiene plus unit-wide chlorhexidine body-washing reduced acquisition of antimicrobial-resistant bacteria, particularly MRSA. In the context of a sustained high level of compliance to hand hygiene and chlorhexidine bathings, screening and isolation of carriers do not reduce acquisition rates of multidrug-resistant bacteria, whether or not screening is done with rapid testing or conventional testing.

FUNDING:

European Commission.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Bacterianas / Portador Sadio / Clorexidina / Infecção Hospitalar / Transmissão de Doença Infecciosa / Desinfetantes / Unidades de Terapia Intensiva Tipo de estudo: Clinical_trials / Diagnostic_studies / Incidence_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Bacterianas / Portador Sadio / Clorexidina / Infecção Hospitalar / Transmissão de Doença Infecciosa / Desinfetantes / Unidades de Terapia Intensiva Tipo de estudo: Clinical_trials / Diagnostic_studies / Incidence_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article